Recession, Gingival
Conditions
Keywords
Subepithelial connective tissue graft, Collagen matrix, Collagen sponge, Soft tissue augmentation, Palatal volumetric change
Brief summary
The goal of this randomized clinical trial is to compare whether soft tissue augmentation placed in the donor site following a gum graft harvesting leads to volumetric changes compared to non-augmented sites in the palate. The main questions it aims to answer are: * Are there tissue thickness changes between the two groups (control group and augmentation group)? * Are there volumetric changes in the donor site (palate) between the two groups in the short and long term? Participants will receive a gum graft and then based on what group they were randomly assigned, they will receive either a collagen matrix where the gum graft was taken (on the palate) or nothing will be placed. Researchers will compare non-augmented sites with augmented sites to see if there is a change in tissue thickness and volume.
Detailed description
The randomized controlled trial aims to investigate the potential effect of post-harvesting donor site augmentation on palatal volumetric changes following connective tissue graft harvesting. The study investigation is a randomized controlled trial (RCT) that aims to have 20 participants in each group. The palatal thickness will be clinically assessed and a digital intraoral scan of the palate will be performed pre-operatively. A subepithelial connect tissue graft will then be harvested from the palate. Patients will then be randomly assigned to receive/not receive augmentation of the donor site, using a collagen sponge. Palatal thickness measurements and intraoral scans will be repeated at 2-, 4-, and 6-months postoperatively.
Interventions
DEVICEUse of collagen matrix after subepithelial connective tissue graft harvest
A collagen matrix is placed under the overlying flap after the subepithelial connective tissue graft harvesting.
Sponsors
Hailey Bivens
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Masking description
Individuals computing the statistical analysis will be masked for which outcome was used. Surgeons and patients will only know which outcome will be used at time of surgery.
Intervention model description
Individuals will be randomly assigned to be in the control group of the intervention group (Collagen matrix soft tissue augmentation).
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Demographic 1. Age: 18-65 years old 2. Gender: Any 3. Race: Any 4. Non-smoker: no use of any tobacco product or nicotine-replacement products in the last 5 years * Medical History 1. Physically and mentally healthy with no contraindications for periodontal surgery 2. American Society of Anesthesiologists: ASA-I or ASA-II * Dental history 1. Periodontally healthy 2. No history of surgical interventions in the palate 3. No history of cleft lip/palate 4. No history of orthodontic treatment involving the palate (palatal expansion). * Other 1. Patients requiring mucogingival surgery involving connective tissue graft harvesting from the palate. 2. Patients who are able and willing to provide informed consent 3. Patients who are able and willing to follow study appointments
Exclusion criteria
* i. Medical History 1. Smokers or users of nicotine replacement products 2. Patients with a contraindication, e.g., allergy, for any of the medications or materials used in the study (benzocaine, lidocaine, chlorhexidine rinse, ibuprofen, acetaminophen, Glycolon ® sutures, collagen sponge matrix) 3. Patients with diabetes (glycemic level \> 110mg/l and HbA1c \> 6.5%) 4. Drug or alcohol abuse history 5. Pregnancy, lactation. 6. Patients with a history of bisphosphonate therapy, radiotherapy in the head and neck region for malignancies, or chemotherapy for treatment of malignant tumors 7. Coagulation disorders or other systemic conditions affecting surgical or wound healing process and gingival tissues, such as cancer, HIV, metabolic bone diseases etc. 8. Medications affecting periodontal status in the previous 6 months 9. Medications affecting surgical or wound healing process and gingival tissues, such as phenytoin, cyclosporine, dihydropyridines, etc. * Dental 1. Patients with any history of palatal surgery 2. Patients with inadequate donor site anatomy 3. Poor oral hygiene 1. Full-mouth plaque ≥ 20% 2. Bleeding scores \> 10% 4. Untreated periodontitis 1. Pocket depths \> 3mm with BOP 2. No active periodontal disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Palatal Thickness Change | 2 months, 4 months, 6 months | Initial palatal thickness of first and second surgery will be measured prior to each surgical incision with an endodontic reamer |
| Palatal Volume Change | 2 months, 4 months, 6 months | Palatal volume change will be compared using an intraoral scan where the scans will be overlayed to compare differences is volume change. |
Countries
United States
Contacts
Primary ContactYing S Wang, DDS, MS
Backup ContactHailey Bivens, DDS
Outcome results
None listed